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Abstract
Background: Primary retroperitoneal mucinous cystadenoma of borderline malignancy represents a rare tumor,
with unclear histogenesis, concerning almost exclusively women. Only two cases concerning male patients have
been reported.
Case report: We herein report a case of a 37 year old man undergone laparotomy for a sizable retroperitoneal
tumor resulting after the histological examination to a primary retroperitoneal mucinous cystadenoma of
borderline malignancy.
Conclusion: This is the third case of primary retroperitoneal mucinous cystadenoma of borderline malignancy in a
male patient reported in the literature. The preoperative diagnosis is impossible. Laparotomy constitutes the only
diagnostic and curative approach.
Background
The primary retroperitoneal mucinous cystadenoma is a
rare tumor that affects, almost exclusively women [1].
The preoperative diagnosis is impossible in most of
cases because of the rarity, the position and the texture
o ft h et u m o r .W er e p o r tac a s eo fa3 7y e a r - o l dm a l e
patient, with primary retroperitoneal mucinous cystade-
noma of borderline malignancy; this may be the third
case registered in the literature.
Case report
A 37 year old man arrived at the outpatient facilities of
our clinic complaining of a remittent pain at the right
lateral abdomen and a palpable mass that was constantly
growing up during the last twelve months. His medical
history included an uneventful appendicectomy in his
childhood, 27 years ago and spontaneous pneumothorax
15 years ago. By that time, he was under medication
with antacids because of gastritis. He did not mention
any evacuation or urination symptoms.
Physical examination revealed a firm, sizeable and
hard mass at the right abdomen (Figure 1), extending
from the inferior ribs to the right iliac crest. Laboratory
findings were within normal limits. The ultrasound (US)
of the abdomen demonstrated a compact mass of
u n e v e ns h a p ea tt h er i g h ta b d o m e n ,e x t e n d e df r o mt h e
liver to the minor pelvis. Abdominal computed tomo-
graphy (CT) scan, demonstrated a cystic textured lesion,
extended from the lower pole of the right kidney to the
right iliac fossa, with a cefalocaudal diameter of 11 cm
(Figure 2). There were small diaphragms within the
mass, enforced by the intravenous administration of a
contrast essence. The tumor was expelling not only the
homolateral ureter but also the small and the large
intestine to the left, however, without any findings of
obstruction. The magnetic resonance imaging (MRI) of
the abdomen demonstrated a cystic tumor with dia-
phragms (Figure 3, Figure 4), extending along the right
abdomen from the inferior pole of the right kidney to
the right iliac crest. The tumor measured a maximum
cefalocaudal diameter of 22 × 10 cm, causing a slight
pressure of the inferior vena cava. The administration of
paramagnetic essence revealed an uneven peripheral
enhancement of signaling. Three focal lesions of
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liver segments II, VI, VII, and VIII, suggesting secondary
metastasis or hemangiomas. Colonoscopy and upper GI
endoscopy was carried out in order to exclude involve-
ment of the gastrointestinal tract. Gastritis was the only
abnormal finding.
The patient underwent laparotomy. A retroperitoneal
cystic mass of gelatinous-like content, arising from the
paravertebral space of the L1-L2-L3 vertebra, was con-
firmed. An “en block” resection of the tumor was per-
formed. The small and the large intestine as well as the
right ureter did not present signs of primary or meta-
static involvement.
The first postoperative hours, the patient complained
of sub-hyperesthesia at the inner surface of the thigh
that was extended to the middle of the calf. In addition,
he asserted a reduction of muscle power at his crur
(thigh flexion debility). Within the next 24 hours, he
underwent an electromyogram which demonstrated a
possible neurogenic damage, due to lesions of the L2-L3
level. Methylprednisolone (250 mg) was administrated
as a single boost dose, followed by dexametasone (8 mg
three times a day). The patient was discharged the
Figure 1 Deformation of the right abdomen due to sizable
retroperitoneal mass in a 37-year old man.
Figure 2 Coronal CT image describing the size of the tumor
and its mass effect to the right kidney.
Figure 3 T2 coronal MR image without fat suppression,
demonstrating the cystic component of the lesion with
internal septa.
Figure 4 Axial T2 MR image with fat suppression revealing the
cystic character of the tumor.
Falidas et al. World Journal of Surgical Oncology 2011, 9:98
http://www.wjso.com/content/9/1/98
Page 2 of 5fourth postoperative day without any other postopera-
tive complication.
The tumor weighed 957 g and measured 22 × 14 × 4,5
cm. The histological examination described internal
cysts within the mass, measuring from 1 to 4 cm in dia-
meter. The thickness of the cystic wall was variable
(from 0,1 to 0,5 cm). Microscopically the inner surface
of the cystic wall revealed filiform and branching papil-
lae lined by mucin-containing atypical epithelial cells
(Figure 5). The lining cells were stratified, generally to
two or three layers, and the nuclear atypia was mild to
moderate. The collagen fibers of the wall were disinte-
grated by pools of mucous, epithelial cells and calcifica-
tions. Lymphocytic infiltration was also observed. The
PAS-D and Alcian Blue stain was positive as well as the
immunihistochemical stain for keratine 8/18, keratine
20, pankeratine, CEA and Ki-67 (Figure 6, Figure 7).
Two months later the patient had a new abdominal
CT-scan which demonstrated absence of residual dis-
ease. The electromyogram was compatible with a
chronic neurogenic damage of the quadriceps muscle.
The next two abdominal CT-scans, performed 6 and 12
months later, showed no recurrence. A significant clini-
cal improvement was observed in patient’s neurological
status, followed by a considerable increase of muscle
power.
Discussion
Primary retroperitoneal tumors are rare (0,01-0,2% of all
neoplasias) [2,3]. Most of them are malignant with char-
acters of a non specific symptomatology. Delayed diag-
nosis of these tumors is common. The most frequent
histological types are fibrosarcomas and liposarcomas.
On the other hand, leiomyofibromas, leiomyosarcomas,
malignant fibrous histiocytomas, neurofibromas, and
rabdomyosarcomas are less common [2,3]. Primary ret-
roperitoneal mucinous cystadenomas (PRMC), mucinous
cystadenomas of borderline malignancy (PRMC-BM)
and cystadenocarcinomas (PRMC-C) are extremely rare
tumors concerning almost exclusively women [1].
Baker et al [1] reviewing the literature from 1966 up
to 2006 identified 45 cases of PRMC and 25 cases of
PRMC-C. In the same study they reported 9 cases of
PRMC-BM, only one case concerned a male patient. In
2009, Roma et al [4] in a retrospective analysis of 18 ret-
roperitoneal mucinous tumors, identified 7 cases of
PRMC-BM. In this study all patients were women. Lai
et al [5] reported the first case of pure PRMC in a male
patient. Motoyama et al [6] reported the first case of
PRMC-BM in a male patient. Two similar cases of
PRMC and PRMC-BM were reported in 2008 and 2009
respectively [7,8]. This paperp r e s e n t st h et h i r dc a s eo f
Figure 5 Hematoxylin and eosin stain demonstrating papillary
formations lined by columnar cells producing mucin, with
moderate cytological atypia (original magnification ×40).
Figure 6 Alcian Blue stain revealing the presence of
intracytoplasmatic mucin (original magnification ×40).
Figure 7 Ki-67 stain revealing positivity of the nuclei of the
epithelial lining cells ranged from 30 to 50% (original
magnification ×20).
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borderline malignancy in a male patient.
Tumors of epithelial derivation located in the retro-
peritoneum are rare because of the non existence of
epithelial cells in this area. Nevertheless, Roth et al [9]
reported Müllerian type epithelium tumors. PRMC and
PRMC-C present histological and morphological charac-
teristics similar to the mucinous tumors of the ovaries
(ovarian-like stroma) [10]. This fact further supports the
theory that tumor’s growth is due to an ectopic or aber-
rant ovarian tissue. However, ovarian tissue has been
rarely detected in histological speciments and in con-
junction to the fact that these tumors appear in men
weakens the theory. Gotoh et al [11] asserted that the
peritoneal epithelium possesses the potential of Müller-
ian differentiation as it appears in almost all the ovarian
tumors. The overgrowing of the mucinous epithelium
on teratoma or genitourinary remnants constitutes two
other theories of this context [12]. However, most of the
authors agree that mucinous tumors originate from
multipotential mesothelial cells, entrapped in the retro-
peritoneum during the growing process. These cells
undergo a mucinous metaplasia, creating cystic muci-
nous inclusions with cytological changes and malignant
phenotypes [13,14].
The preoperative diagnosis is difficult because of the
non specific presenting symptoms and the vague preo-
perative imaging tests. The mucinous cystadenoma is
usually asymptomatic. Abdominal discomfort or sick-
ness, distension or pain and rarely intermittent intestinal
occlusion are the most common reported symptoms
[2,3,13,14]. Acute abdomen due to intestinal obstruction
caused by retroperitoneal mucinous cystadenoma has
also been reported [15].
Preoperative studies with US, CT and MRI identify
abdominal masses, often reveal the nature of the
tumors, but insufficient to lead to a definite diagnosis.
Matsubaras et al [13] in a review effectuated from 1966
to 2005 found only two reports concerning the preo-
perative “suspicion” of a retroperitoneal cystic tumor.
Others, like Thamboo [16] consider that the CT exami-
nation lays the suspicion of a retroperitoneal tumor,
provided other elements are seriously considered like
the displacement of the ureter, kidneys, and large vessels
or intestine.
The abdominal US is not specific [5], may reveal the
unilobular or multilobular tumor’s character but is
unable to determine its origin and extension. The diag-
nostic value of CT and MRI is similar. CT scan,
although easily accessible, exposes the patient in irradia-
tion and does not offer an adequate description of the
tumor’s relation with the soft tissues [5]. However, CT
reveals the extension of the mass and shows better
mural calcifications. The later, are considered to be
important findings in the differential diagnosis between
cystic teratoma and cystadenoma. Calcifications found
within the mass support the diagnosis of teratoma while
mural calcifications enforce the suspicion of cystade-
noma [17]. On the other hand, MRI offers a rich variety
of images and reveals better the correlations between
the mass and the soft tissues. MRI seems to be more
specific in describing the extension of the mass in the
pelvis. The various scans allow the surgeon to determine
possible associations between the mass and the pan-
creas, the kidneys and the ovaries, organs that could be
potentially implicated in similar cystic lesions [5,13,16].
In our case, the tumor was recognized by US and its
extension and association with the neighboring organs
was estimated by CT and MRI. Lymphangiomas, cystic
teratomas, lymphoceles, urinomas and cystic mesothelio-
mas were also included in the differential diagnosis. The
tumor markers do not seem to have any specificity
n e i t h e ra tP R M C - B Mn o ra tP R M C - C[ 1 2 , 1 4 ] .I no u r
case, tumor markers (CA-125, CA-19.9, and CEA) were
within normal limits. Fine Needle Aspiration (FNA)
under the guidance of US or CT is rarely diagnostic
because the taken material mainly represents the core
of the tumor, which is mostly consisted of mucus,
thus unable to demonstrate histopathological character-
istics [6].
Although the laparotomy has a double role, diagnos-
tic as well as curative, the approach may be different
in accordance to sex. There is a general agreement
that a radical resection should be performed in both
sexes [15]. The laparoscopic removal has been suc-
cessfully proposed in a number of retroperitoneal
tumors, such as adrenal and perirenal tumors. Chens
et al [18] presented the first laparoscopic resection of
retroperitoneal mucinous cystadenoma of borderline
malignancy in 1998. In women with PRMC-C, some
authors suggest ovariectomy [11], others suggest hys-
terectomy [19] while some of them keep an aggressive
treatment for women during the post-menopause
period [20].
Due to the small amount of cases reported in the
international literature, investigators could not justify
any adjuvant chemotherapy protocols. The surgical pro-
cedure seems to be sufficient for the PRMC and the
PRMC-BM, especially if there is not any eruption of the
cystadenoma’s capsule. Some authors suggest che-
motherapy for the PRMC-C, based on the possible com-
mon mechanisms of histogenesis of these rare tumors
with the mucinous tumors of the ovaries [15]. The small
number of globally registered cases, the insufficient sur-
veillance data and mainly the inability to understand
which patients are in higher risk of recurrence, show
that there is a need of an effective registration and
further study of these rare tumors [12,21].
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low up of 24 months. Since there are no clear recom-
mendations for surveillance concerning PRMC-BM, we
proposed clinical and US examinations every six
months, as well as imaging studies every year by either
MRI or CT.
Conclusion
We present a rare case of primary retroperitoneal muci-
nous cystadenoma of borderline malignancy in a male
patient. These tumors are only twice reported in the lit-
erature. The preoperative diagnosis is difficult and lapar-
otomy has been the standard approach for both
diagnosis and treatment. Postoperative follow-up guide-
lines should get proposed. More similar cases must get
registered, so that research defines new protocols for
treatment for this domain.
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